Filters

Schizosaccharomyces pombe Chromatin modification-related protein eaf3 (alp13)

Schizosaccharomyces pombe Chromatin modification-related protein eaf3 (alp13) size: 100ug 1967

Supplier MBS RECOMBINANT PROTEINS
Price 1967
Size 100ug
Contact us Ask Component cell markers and DNA bp. markers are genetic markerser genes or DNA sequenceswith selection audit
Long nameRecombinant Schizosaccharomyces pombe Chromatin modification-related protein eaf3 (alp13)
Alternative names Altered polarity protein 13, Chromatin modification-related protein eaf3, ESA1-associated factor 3, MRG family Clr6 histone deacetylase complex subunit Alp13, MRG family Clr6 histone deacetylase complex subunit Alp13
Gene namealp13
Other gene names alp13, eaf3, alp13
General description All of our recombinant proteins are manufactured in strictly controlled facilities and by using a well established technology which guarantees full batch-to-bact consistency and experiment reproducibility, The protein can be with or without a His-Tag or other tag in accordance to customer's request, Chromatin modification-related protein eaf3 (alp13) is a recombinant protein expressed in Baculovirus
Product categoryRecombinant Proteins
Expression systemBaculovirus
Available also expressed in: Baculovirus , Mammalian Cell, Yeast , E Coli
PurityGreater than 90% (determined by SDS-PAGE)
FormLyophilized protein
Storage Avoid cycles of freezing and thawing as they might denaturate the polypeptide chains, For extended periods of time it is recommended to keep the protein frozen at -40 or -80 degrees Celsius, This protein can be stored at -20 degrees Celsius
Applications IFA, RIA, Western Blot, etc, This protein can be used as a positive control for applications such as ELISA
Gene targetSchizosaccharomyces pombe Chromatin modification-related protein eaf3 (alp13)
Short nameSchizosaccharomyces pombe Chromatin modification-related protein eaf3 (alp13)
Alternative nameSchizosaccharomyces pombe Chromatin modification-related protein eaf3 (alp13)

Similar products

Subscribe to our Newsletter